Related Experiment Video
Updated: Jun 2, 2026

Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
One foundation's strategy to accelerate drug discovery through genomics
Louise M Perkins1, Anne Quinn Young, Kathy Giusti
1Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium, Norwalk, CT 06851, USA.
Abstract:
The Multiple Myeloma Research Foundation (MMRF) has the principal goal of accelerating development of next-generation drugs for treating multiple myeloma. By making targeted investments in key research areas such as genomics and epigenetics, the MMRF is helping to elucidate the basic biology of multiple myeloma, to drive promising new treatments into clinical development, and ultimately to link the right treatment to the right patient.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview
Genomics
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenetics and Pharmacogenomics: Overview

